GIA
MIRM icon

GHP Investment Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

GHP Investment Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118 Hold
1
– – ﹤0.01% 1256
2026
Q1 		$93 Buy
+1
New +$94 ﹤0.01% 1311

Other funds holding MIRM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HP
Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

GHP Investment Advisors's MIRM Position: Q2 2026 in Review

GHP Investment Advisors held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 1 share worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

GHP Investment Advisors first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • GHP Investment Advisors held 1 share of Mirum Pharmaceuticals worth $118 as of Q2 2026.
  • GHP Investment Advisors left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1256 holding.
  • GHP Investment Advisors first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 71 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.